Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancer
Li C. Xia, Paul Van Hummelen, Matthew A. Kubit, HoJoon Lee, John Bell, Susan M. Grimes, Christina M. Wood-Bouwens, Stephanie Greer, Tyler Barker, Derrick S. Haslem, James M. Ford, Gail Fulde, Hanlee P. Ji, Lincoln D. Nadauld
The paper identifies TP53 genomic deletions as a poor prognosis marker in Stage III colorectal cancer using a new low-coverage whole-genome sequencing protocol.
Scientific Reports · Mar 19, 2020Peer-reviewedGenomics